Isolated reduction of haematocrit does not compromise in vitro blood coagulation.

Low haematocrit values are generally well tolerated in terms of oxygen transport but a low haematocrit might interfere with blood coagulation. We thus sampled 60 ml of blood in 30 healthy volunteers. The blood was centrifuged for 30 min at 2000 g and separated into plasma, which contained the platelet fraction, and packed red blood cells. The blood was subsequently reconstituted by combining the entire plasma fraction with a mixture of packed red blood cells, 0.9% saline, so that the final haematocrit was either 40, 30, 20, or 10%. Blood coagulation was assessed by computerized Thrombelastograph analysis. Data were compared using repeated measures analysis of variance and post-hoc paired t-tests with Bonferroni correction. Decreasing the haematocrit from 40 to 10% resulted in a shortening of reaction time (r) and coagulation time (k), and an increase in angle alpha, maximum amplitude (MA) and clot strength (G) (all P<0.02). This pattern represents acceleration of blood coagulation with low haematocrit values. The isolated reduction in haematocrit, therefore, does not compromise in vitro blood coagulation.

[1]  J. Loscalzo,et al.  The red cell transfusion trigger: has a sin of commission now become a sin of omission? , 1998, Transfusion.

[2]  M. James,et al.  In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. , 1998, British journal of anaesthesia.

[3]  W. O’Neill,et al.  Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. , 1997, The Journal of laboratory and clinical medicine.

[4]  M. Singer,et al.  Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial , 1997, BMJ.

[5]  C. Whitten,et al.  Thromboelastography: past, present, and future. , 2000, Anesthesiology.

[6]  D. A. Dick.  The red cell. , 1972, British medical journal.

[7]  A. Burroughs,et al.  Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding , 1998, Gut.

[8]  Yoogoo Kang,et al.  Thromboelastography in Liver Transplantation , 1995, Seminars in Thrombosis & Hemostasis.

[9]  J. Treib,et al.  Coagulation Disorders Caused by Hydroxyethyl Starch , 1997, Thrombosis and Haemostasis.

[10]  M. Thick,et al.  Reversal of post-reperfusion coagulopathy by protamine sulphate in orthotopic liver transplantation. , 1994, British journal of anaesthesia.

[11]  S. Bratton,et al.  Coagulation tests during cardiopulmonary bypass correlate with blood loss in children undergoing cardiac surgery. , 1999, Journal of cardiothoracic and vascular anesthesia.

[12]  V. Nielsen,et al.  Evaluation of the Contribution of Platelets to Clot Strength by Thromboelastography in Rabbits: The Role of Tissue Factor and Cytochalasin D , 2000, Anesthesia and analgesia.

[13]  D. Warner.  Isoflurane neuroprotection: a passing fantasy, again? , 2000, Anesthesiology.

[14]  B. Seifert,et al.  Low- and Medium-molecular-weight Hydroxyethyl Starches: Comparison of Their Effect on Blood Coagulation , 2000, Anesthesiology.

[15]  B. Seifert,et al.  Citrate Storage Affects Thrombelastograph® Analysis , 2000, Anesthesiology.

[16]  P Coriat,et al.  Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. , 1999, Anesthesiology.

[17]  C. Valeri,et al.  The volume of blood shed during the bleeding time correlates with the peripheral venous hematocrit. , 1997, American journal of clinical pathology.

[18]  P. Comfurius,et al.  Mechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes. , 1993, Biochemical Society transactions.

[19]  S. Mezzano,et al.  Hemostatic Disorder of Uremia: The Platelet Defect, Main Determinant of the Prolonged Bleeding Time, Is Correlated with Indices of Activation of Coagulation and Fibrinolysis , 1996, Thrombosis and Haemostasis.

[20]  G. Nuttall,et al.  Does the Platelet-Activated Clotting Test (HemoSTATUS[registered sign]) Predict Blood Loss and Platelet Dysfunction Associated with Cardiopulmonary Bypass? , 1997, Anesthesia and analgesia.

[21]  M. James,et al.  Haemodilution induces a hypercoagulable state. , 1996, British journal of anaesthesia.

[22]  V. Nielsen,et al.  Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. , 2000 .

[23]  B. Seifert,et al.  Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. , 1997, British journal of anaesthesia.

[24]  K. Boudjema,et al.  Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients. , 1994, British journal of anaesthesia.

[25]  J. Reves,et al.  Cardiovascular and Coronary Physiology of Acute Isovolemic Hemodilution: A Review of Nonoxygen‐Carrying and Oxygen‐Carrying Solutions , 1994, Anesthesia and analgesia.

[26]  D. Spahn,et al.  Eliminating Blood Transfusions: New Aspects and Perspectives , 2000, Anesthesiology.

[27]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[28]  R. Strauss,et al.  Pentastarch may cause fewer effects on coagulation than hetastarch , 1988, Transfusion.

[29]  J. Herbert,et al.  Contribution of Erythrocytes to Thrombin Generation in Whole Blood , 1999, Thrombosis and Haemostasis.